These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 24920768)

  • 21. Immune responses in Ugandan women infected with subtypes A and D HIV using the BED capture immunoassay and an antibody avidity assay.
    Longosz AF; Morrison CS; Chen PL; Arts E; Nankya I; Salata RA; Franco V; Quinn TC; Eshleman SH; Laeyendecker O
    J Acquir Immune Defic Syndr; 2014 Apr; 65(4):390-6. PubMed ID: 24583613
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of HIV type 1 genetic diversity among South African participants enrolled in the AIDS Vaccine Integrated Project (AVIP) study.
    Papathanasopoulos MA; Vardas E; Wallis C; Glashoff R; Buttó S; Poli G; Malnati M; Clerici M; Ensoli B
    AIDS Res Hum Retroviruses; 2010 Jun; 26(6):705-9. PubMed ID: 20509797
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIV-1 subtype B/B' and baseline drug resistance mutation are associated with virologic failure: a multicenter cohort study in China.
    Li Y; Gu L; Han Y; Xie J; Wang H; Lv W; Song X; Li Y; Iwamoto A; Ishida T; Li T;
    J Acquir Immune Defic Syndr; 2015 Mar; 68(3):289-97. PubMed ID: 25501612
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of a current hot spot of HIV type 1 transmission in Mongolia by molecular epidemiological analysis.
    Davaalkham J; Unenchimeg P; Baigalmaa C; Erdenetuya G; Nyamkhuu D; Shiino T; Tsuchiya K; Hayashida T; Gatanaga H; Oka S
    AIDS Res Hum Retroviruses; 2011 Oct; 27(10):1073-80. PubMed ID: 21417756
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection and molecular characterization of urinary tract HIV-1 populations.
    Mzingwane ML; Hunt G; Lassauniere R; Kalimashe M; Bongwe A; Ledwaba J; Chaisson RE; Martinson N; Richter K; Bowyer SM; Tiemessen CT
    Ann Clin Microbiol Antimicrob; 2019 Sep; 18(1):27. PubMed ID: 31551072
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic analyses of HIV-1 pol sequences from Zimbabwean patients.
    Falasca F; Temperoni C; Mazzuti L; Lo Presti A; Ciccozzi M; Di Filippo E; Iaiani G; Taliani G; Turriziani O
    New Microbiol; 2014 Jul; 37(3):377-81. PubMed ID: 25180853
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Short communication: Molecular characterization of HIV type 1 BF pol recombinants from São Paulo, Brazil.
    de Souza AC; de Oliveira CM; Rodrigues CL; Silva SA; Levi JE
    AIDS Res Hum Retroviruses; 2008 Dec; 24(12):1521-5. PubMed ID: 19025398
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence of HIV type 1 infection, antiretroviral drug resistance, and molecular characterization in newly diagnosed individuals in Argentina: A Global Fund Project.
    Pando MA; Gómez-Carrillo M; Vignoles M; Rubio AE; dos Ramos Farias MS; Vila M; Rossi D; Ralón G; Marone R; Reynaga E; Sosa J; Torres O; Maestri M; Avila MM; Salomón H
    AIDS Res Hum Retroviruses; 2011 Jan; 27(1):17-23. PubMed ID: 20860532
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Using the pol gene sequence results in clinical practice and HIV epidemiology].
    Volova LIu; Grezina LA
    Zh Mikrobiol Epidemiol Immunobiol; 2008; (4):92-5. PubMed ID: 18819415
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HIV-1 genetic transmission networks among men who have sex with men in Kunming, China.
    Chen M; Ma Y; Chen H; Dai J; Dong L; Yang C; Li Y; Luo H; Zhang R; Jin X; Yang L; Cheung AKL; Jia M; Song Z
    PLoS One; 2018; 13(4):e0196548. PubMed ID: 29698467
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Molecular characterization of complex recombinant HIV-1 CRF06_cpx subtype detected in Turkey].
    Sayan M; Kaptan F; Ormen B; Türker N
    Mikrobiyol Bul; 2014 Jan; 48(1):160-7. PubMed ID: 24506727
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determination of mean recency period for estimation of HIV type 1 Incidence with the BED-capture EIA in persons infected with diverse subtypes.
    Parekh BS; Hanson DL; Hargrove J; Branson B; Green T; Dobbs T; Constantine N; Overbaugh J; McDougal JS
    AIDS Res Hum Retroviruses; 2011 Mar; 27(3):265-73. PubMed ID: 20954834
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Significantly diminished long-term specificity of the BED capture enzyme immunoassay among patients with HIV-1 with very low CD4 counts and those on antiretroviral therapy.
    Marinda ET; Hargrove J; Preiser W; Slabbert H; van Zyl G; Levin J; Moulton LH; Welte A; Humphrey J
    J Acquir Immune Defic Syndr; 2010 Apr; 53(4):496-9. PubMed ID: 20306555
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epidemiological, Clinical and Antiretroviral Susceptibility Characterization of Human Immunodeficiency Virus Subtypes B and Non-B in Pernambuco, Northeast Brazil.
    Lima K; de Souza Leal É; Cavalcanti AM; Salustiano DM; de Medeiros LB; da Silva SP; Lacerda HR
    PLoS One; 2016; 11(5):e0155854. PubMed ID: 27218259
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic diversity of HIV-1 and transmitted drug resistance among newly diagnosed individuals with HIV infection in Hangzhou, China.
    Zhang J; Guo Z; Yang J; Pan X; Jiang J; Ding X; Zhang W; Xia Y; Xu Y; Huang J
    J Med Virol; 2015 Oct; 87(10):1668-76. PubMed ID: 25899877
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and Evaluation of a Modified Fourth-Generation Human Immunodeficiency Virus Enzyme Immunoassay for Cross-Sectional Incidence Estimation in Clade B Populations.
    Kirkpatrick AR; Patel EU; Celum CL; Moore RD; Blankson JN; Mehta SH; Kirk GD; Margolick JB; Quinn TC; Eshleman SH; Laeyendecker O
    AIDS Res Hum Retroviruses; 2016 Aug; 32(8):756-62. PubMed ID: 26988426
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Specificity of four laboratory approaches for cross-sectional HIV incidence determination: analysis of samples from adults with known nonrecent HIV infection from five African countries.
    Laeyendecker O; Brookmeyer R; Mullis CE; Donnell D; Lingappa J; Celum C; Baeten JM; Campbell MS; Essex M; de Bruyn G; Farquhar C; Quinn TC; Eshleman SH;
    AIDS Res Hum Retroviruses; 2012 Oct; 28(10):1177-83. PubMed ID: 22283149
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparison of two measures of HIV diversity in multi-assay algorithms for HIV incidence estimation.
    Cousins MM; Konikoff J; Sabin D; Khaki L; Longosz AF; Laeyendecker O; Celum C; Buchbinder SP; Seage GR; Kirk GD; Moore RD; Mehta SH; Margolick JB; Brown J; Mayer KH; Kobin BA; Wheeler D; Justman JE; Hodder SL; Quinn TC; Brookmeyer R; Eshleman SH
    PLoS One; 2014; 9(6):e101043. PubMed ID: 24968135
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transmitted HIV Type 1 drug resistance and Non-B subtypes prevalence among seroconverters and newly diagnosed patients from 1992 to 2005 in Italy.
    Riva C; Lai A; Caramma I; Corvasce S; Violin M; Dehò L; Prati F; Rossi C; Colombo MC; Capetti A; Franzetti M; Rossini V; Tambussi G; Ciccozzi M; Suligoi B; Mussini C; Rezza G; Balotta C
    AIDS Res Hum Retroviruses; 2010 Jan; 26(1):41-9. PubMed ID: 20055587
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characteristics of HIV-1 Molecular Epidemiology in Suzhou, China, from 2009 to 2014.
    Yuan Y; Tang S; Li Y; Yan D; Peng Q; Ya X; Song Y
    Virol Sin; 2018 Apr; 33(2):209-212. PubMed ID: 29549651
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.